NuVasive, Inc. v. Day

954 F.3d 439
CourtCourt of Appeals for the First Circuit
DecidedApril 8, 2020
Docket19-1611P
StatusPublished
Cited by38 cases

This text of 954 F.3d 439 (NuVasive, Inc. v. Day) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
NuVasive, Inc. v. Day, 954 F.3d 439 (1st Cir. 2020).

Opinion

United States Court of Appeals For the First Circuit

No. 19-1611

NUVASIVE, INC.,

Plaintiff-Appellee,

v.

TIMOTHY DAY,

Defendant-Appellant.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS

[Hon. Denise J. Casper, U.S. District Judge]

Before

Howard, Chief Judge, Thompson and Barron, Circuit Judges.

Bryan E. Busch, with whom Busch Slipakoff Mills & Slomka, LLC, Steven D. Weatherhead, and Marathas Barrow Weatherhead Lent LLP were on brief, for appellant. Mary Taylor Gallagher, with whom Holly M. Polglase, Michael S. Batson, Hermes, Netburn, O'Connor & Spearing, P.C., Christopher W. Cardwell, M. Thomas McFarland, and Gullett, Sanford, Robinson & Martin, PLLC, were on brief, for appellee.

April 8, 2020 BARRON, Circuit Judge. In this appeal, Timothy Day, a

Massachusetts resident, challenges a preliminary injunction that

the United States District Court for the District of Massachusetts

granted to his former employer, NuVasive, Inc., which is a health-

care company incorporated in Delaware. The injunction, which

enforces a nonsolicitation clause in the employment contract

between Day and NuVasive, bars Day from engaging in certain work

for his new employer, Alphatec Spine, Inc., which is one of

NuVasive's competitors.

Day's challenge to the injunction turns on a choice-of-

law issue under Massachusetts law. The District Court held that

Massachusetts' choice-of-law rules permitted it to enforce the

choice-of-law provision set forth in Day's employment contract

with NuVasive, which explicitly stated that the "[a]greement shall

be interpreted and enforced in accordance with Delaware law,

without giving effect to its laws pertaining to conflict of laws."

The District Court thus premised its issuance of the preliminary

injunction that is at issue on its application of Delaware law.

Day contends, however, that Massachusetts' choice-of-law rules

required the District Court to apply Massachusetts law and that,

under Massachusetts law, NuVasive could not show that it was

entitled to the preliminary injunction, even if NuVasive could

make that showing under Delaware law. We affirm.

- 2 - I.

NuVasive designs and manufactures products for the

treatment of spine disease. NuVasive distributes these products

through both its own employees and exclusive distributors.

Day first became affiliated with NuVasive in 2008 while

he was working for Integrity Medical, Inc., which at the time was

an exclusive distributor for NuVasive. Thereafter, Day became an

employee of NuVasive, where he worked as a sales representative

from August of 2011 until December of 2012.

At that time, Day left NuVasive to become a sales

representative for another one of NuVasive's exclusive

distributors, Magellan Medical LLC. But, five years later, on

January 1, 2018, Day once again became an employee of NuVasive,

this time as a sales director for the company in Massachusetts and

Rhode Island.

It was during this period of employment with NuVasive

that Day signed, as a condition of his employment, a Proprietary

Information, Inventions Assignment, Arbitration and Restrictive

Covenant Agreement ("PIIA"). The PIIA included a nonsolicitation

clause and a noncompetition clause, which applied during Day's

engagement with NuVasive and for one year immediately after.1

1 The nonsolicitation clause provides, in relevant part, that the employee agrees not to:

- 3 - On January 3, 2019, however, Day once again left

NuVasive, this time to become an employee and owner of Rival

Medical LLC, which was, at that time, itself an exclusive

distributor for NuVasive. But, then, several months later, in

solicit, entice, persuade, induce, call upon or provide services to any of the Customers . . . , accounts or clients that [the employee] worked with, had responsibility or oversight of, provided services related to, or learned significant information about during my employment (or other association) with the Company for any purpose other than for the benefit of the Company . . . .

And, the noncompetition clause forbids the employee from any affiliation with a "Conflicting Organization," which is defined as:

any person, group of persons, or organization that is engaged in, or about to be engaged in, research on, consulting regarding, or development, production, marketing or selling of any product, process, invention or service, which resembles, competes with, or replaces a product, process, machine, invention or service upon which [the employee] shall have worked or about which [the employee] became knowledgeable as a result of [the employee's] relationship with the Company, and whose use or marketability could be enhanced by the application of Proprietary Information to which [the employee] shall have had access during such relationship.

For employees with certain titles, including Sales Director, Sales Associate, and "any substantially similar position[s]," the "post- employment restrictions" described in the noncompetition clause are limited to Customers for which the employee "was assigned responsibility for by the Company, participated in sales calls and/or marketing efforts on behalf of the Company, and/or covered medical procedures on behalf of Company, during the last twelve months of [the employee's] employment with Company."

- 4 - April of 2019, Day dissolved Rival and terminated its relationship

with NuVasive.

In response, NuVasive sent Day and Rival a notice of

material breach of contract. Notable for present purposes,

NuVasive also reminded Day of his noncompetition and

nonsolicitation obligations under the PIIA. Nonetheless, soon

after ending his employment at Rival, Day began working as an

employee of Alphatec Spine, which is one of NuVasive's competitors.

At that point, NuVasive sued Day in the District of Massachusetts

based on its diversity jurisdiction. See 28 U.S.C. § 1332.

NuVasive's complaint against Day alleged tortious

interference and breach of contract and requested a preliminary

injunction to bar Day from violating his noncompetition and

nonsolicitation obligations under the PIIA in his work for

Alphatec. Day opposed the request for the preliminary injunction

on the ground that, notwithstanding the choice-of-law provision in

his contract with NuVasive, Massachusetts rather than Delaware law

applied to NuVasive's breach of contract claims and that those

claims must be dismissed under Massachusetts law. NuVasive

countered that, pursuant to the choice-of-law provision contained

in its employment contract with Day, Delaware law applied to the

breach of contract claims and that, under Delaware law, Day's

opposition to the request for the preliminary injunction lacked

merit.

- 5 - To resolve the threshold choice-of-law dispute

concerning NuVasive's breach of contract claims, the District

Court applied Massachusetts' choice-of-law rules.2 The District

Court then held that, under those rules, the choice-of-law

provision in Day's employment contract with NuVasive governed.

The District Court thus held that Delaware law applied to

NuVasive's breach of contract claims and that, although NuVasive

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
954 F.3d 439, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nuvasive-inc-v-day-ca1-2020.